SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001553878-16-000047
Filing Date
2016-06-07
Accepted
2016-06-07 16:43:48
Documents
1
Period of Report
2016-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3526
  Complete submission text file 0001553878-16-000047.txt   4951
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELI LITTY & CO LIIY CORPORATE CENTER DC 1093 INDIANAPOLIS IN 46285
Business Address
PAUL STEVEN M (Reporting) CIK: 0001237564 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 161701742